|
⚲
|
| Keyboard |
| Bruce Carter | |
|---|---|
| Firm | |
| Address | c/o Navigating Cancer, Inc 1008 Western Ave, Suite 206 Seattle, WA 98101 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Navigating Cancer Inc | 021-324673 | Director | of 1.5 M |
||
| Biothera Holding Corp | 021-229844 | Director | 1.6 M of 57.0 M |
||
| Metheor Therapeutics Corp | 021-228045 | Director | 0.1 M of 0.2 M |
||
| Bank of Queensland Ltd | 021-216986 | Director | 26.7 M of 26.7 M |
||
| Regulus Therapeutics Inc | 021-211442 | Director | 10.0 M of 10.0 M |
||
| Immune Design Corp | 021-205531 | Director | 48.5 M of 57.8 M |
||
| Xencor Inc | 021-198890 | Director | 7.6 M of 10.0 M |
||
| Regulus Therapeutics Inc | 021-185940 | Director | 5.0 M of 5.0 M |
||
| Regulus Therapeutics Inc | 021-185938 | Director | 25.0 M of 25.0 M |
||
| Xencor Inc | 021-152529 | Director | 7.5 M of 7.5 M |
||
| Moksha8 Inc | 021-149114 | Director | 61.0 M of 81.0 M |
||
| Immune Design Corp | 021-145953 | Director | 34.0 M of 34.0 M |
||
| Moksha8 Inc | 021-143312 | Director | 2.5 M of 10.0 M |
||
| Moksha8 Inc | 021-98747 | Director | 25.1 M of 35.0 M |
||